We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+7.98%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.25B
AUM Growth
-$1.7B
Cap. Flow
-$2.08B
Cap. Flow %
-33.31%
Top 10 Hldgs %
54.24%
Holding
331
New
77
Increased
88
Reduced
65
Closed
73

Top Buys

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$41.6M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$39M
3
DPZ icon
Domino's
DPZ
+$33.2M
4
INCY icon
Incyte
INCY
+$27.6M
5
HUM icon
Humana
HUM
+$26.5M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$109M
2
EXAS
Exact Sciences
EXAS
+$59.2M
3
SNY icon
Sanofi
SNY
+$49.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$49.6M
5
GSK icon
GSK
GSK
+$39.9M

Sector Composition

Rank Sector Weight
1 Healthcare 41.55%
2 Consumer Discretionary 7.13%
3 Consumer Staples 5.35%
4 Technology 5.24%
5 Communication Services 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COTY icon
101
Coty
COTY
$2.49B
$8.56M 0.14%
911,706
+25,182
+3% +$240K
IRON icon
102
Disc Medicine
IRON
$3.03B
$7.86M 0.13%
+160,000
New +$7.51M
ORLY icon
103
O'Reilly Automotive
ORLY
$76.3B
$7.6M 0.12%
98,940
-43,260
-30% -$3.18M
WH icon
104
Wyndham Hotels & Resorts
WH
$5.65B
$7.55M 0.12%
+96,676
New +$7.34M
ANGO icon
105
AngioDynamics
ANGO
$622M
$7.48M 0.12%
962,000
+126,000
+15% +$910K
ALC icon
106
Alcon
ALC
$34.4B
$7.08M 0.11%
+70,740
New +$6.65M
TGT icon
107
Target
TGT
$67.1B
$7.07M 0.11%
45,373
-21,146
-32% -$3.15M
SNN icon
108
Smith & Nephew
SNN
$12.7B
$6.98M 0.11%
+224,000
New +$6.65M
GB
109
DELISTED
Global Blue Group Holding
GB
$6.64M 0.11%
1,214,475
– –
NOMD icon
110
Nomad Foods
NOMD
$1.65B
$6.5M 0.1%
+340,913
New +$6.28M
PATH icon
111
UiPath
PATH
$7.16B
$6.28M 0.1%
490,615
-235,905
-32% -$2.89M
ZURA icon
112
Zura Bio
ZURA
$536M
$6.09M 0.1%
1,500,000
-1,024,000
-41% -$3.83M
ELDN icon
113
Eledon Pharmaceuticals
ELDN
$266M
$5.89M 0.09%
2,364,000
+28,000
+1% +$75K
CRVO icon
114
CervoMed
CRVO
$26M
$5.87M 0.09%
402,000
-238,000
-37% -$3.69M
EOLS icon
115
Evolus
EOLS
$407M
$5.83M 0.09%
360,000
– –
AXGN icon
116
Axogen
AXGN
$2.43B
$5.61M 0.09%
+400,055
New +$4.42M
RANI icon
117
Rani Therapeutics
RANI
$87.7M
$5.56M 0.09%
+2,574,000
New +$7.38M
CROX icon
118
Crocs
CROX
$6.58B
$5.52M 0.09%
+38,130
New +$5.2M
VNRX icon
119
VolitionRx Ltd
VNRX
$9.58M
$5.41M 0.09%
+449,936
New +$5.79M
ASMB icon
120
Assembly Biosciences
ASMB
$526M
$5.36M 0.09%
354,000
-114,000
-24% -$1.74M
GOOS
121
Canada Goose Holdings
GOOS
$861M
$5.35M 0.09%
427,000
+92,000
+27% +$1.04M
MURA
122
DELISTED
Mural Oncology
MURA
$5.32M 0.09%
1,700,000
+12,000
+0.7% +$39.1K
ETSY icon
123
Etsy
ETSY
$8.15B
$5.01M 0.08%
+90,164
New +$5.12M
BLMN icon
124
Bloomin' Brands
BLMN
$1.01B
$4.96M 0.08%
300,000
+175,000
+140% +$3.1M
DNMR
125
DELISTED
Danimer Scientific, Inc.
DNMR
$4.9M 0.08%
269,700
+9,100
+3% +$159K
3 4
5
6 7

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Armistice Capital held 331 positions worth $6.25B, down 21% from $7.95B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Armistice Capital withdrew a net $2.08B in Q3 2024, closing 73 positions and reducing 65 holdings. Its most notable exit was Exact Sciences, an estimated $59.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Armistice Capital opened a new position in Paramount Global Class B worth $21.2M.

  • Armistice Capital's largest Q3 2024 buy was Paramount Global Class B: 2,000,000 shares worth $21.2M.
  • Armistice Capital added most to FIVE9 in Q3 2024, an estimated $41.6M increase.
  • Armistice Capital's biggest Q3 2024 reduction was Neurocrine Biosciences, cutting an estimated $109M.
  • Armistice Capital fully exited Exact Sciences in Q3 2024, selling an estimated $59.2M.
  • Armistice Capital's ten largest holdings make up 54% of its $6.25B portfolio in Q3 2024.
  • Armistice Capital opened 77 new positions and closed 73 in Q3 2024.
  • Armistice Capital's portfolio value fell 21% quarter-over-quarter to $6.25B.

Based on Armistice Capital's 13F filing for Q3 2024, filed 14 Nov 2024.